Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease

Purpose. To examine the indicators of iron deficiency, the levels of hemoglobin, erythropoietin, hypoxia-induced factor 1-alpha (HIF-1α) in the blood of children with anemia and chronic kidney disease C1-5 prior to the dialysis and on its background, receiving and not receiving iron preparations and...

Full description

Bibliographic Details
Main Authors: E. V. Leonteva, N. D. Savenkova
Format: Article
Language:Russian
Published: Ltd. “The National Academy of Pediatric Science and Innovation” 2020-03-01
Series:Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:
Online Access:https://www.ped-perinatology.ru/jour/article/view/1061
_version_ 1797875209675472896
author E. V. Leonteva
N. D. Savenkova
author_facet E. V. Leonteva
N. D. Savenkova
author_sort E. V. Leonteva
collection DOAJ
description Purpose. To examine the indicators of iron deficiency, the levels of hemoglobin, erythropoietin, hypoxia-induced factor 1-alpha (HIF-1α) in the blood of children with anemia and chronic kidney disease C1-5 prior to the dialysis and on its background, receiving and not receiving iron preparations and erythropoietin-stimulating drugs to establish the role of HIF-1α in the regulation of erythropoietin synthesis and erythropoiesis. Results. The patients (n=80) with anemia and chronic kidney disease were divided into 3 groups: Group 1: 32 patients with chronic kidney disease C1-5 prior to the dialysis, not receiving therapy; Group 2: 18 patients with chronic kidney disease C2-5 prior to the dialysis, receiving iron-containing preparations and erythropoietin-stimulating drugs; Group 3: 30 patients with chronic kidney disease C3-5 on dialysis, receiving iron preparations and erythropoietin-stimulating drugs. Group 1: we found the increased levels of erythropoietin (28.65 ± 3.66 MIU/ml) and HIF-1α (0.089 ± 0.011 ng/ml; p=0.014 and p=0.005, respectively); Group 2: 63.01 ± 14.84 mIU/ml and 0.138 ± 0.025 ng/ml; p=0.0088 and p=0.005, respectively). Group 3: we found the increased level of HIF-1α (0.098 ± 0.01 ng/ml; p=0.005).Conclusion. An increase in concentration of HIF-1α in children with anemia and chronic kidney disease C1-5 prior and on dialysis receiving and not receiving therapy with iron-containing drugs and erythropoietin-stimulating agents confirms the role of HIF-1α in the regulation of erythropoietin and erythropoiesis synthesis in anemia.
first_indexed 2024-04-10T01:42:56Z
format Article
id doaj.art-e9e5fac032c24a45870699088ad98d7f
institution Directory Open Access Journal
issn 1027-4065
2500-2228
language Russian
last_indexed 2024-04-10T01:42:56Z
publishDate 2020-03-01
publisher Ltd. “The National Academy of Pediatric Science and Innovation”
record_format Article
series Rossijskij Vestnik Perinatologii i Pediatrii
spelling doaj.art-e9e5fac032c24a45870699088ad98d7f2023-03-13T09:12:48ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282020-03-01651778510.21508/1027-4065-2020-65-1-77-85848Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney diseaseE. V. Leonteva0N. D. Savenkova1ФГБОУ ВО «Cанкт-Петербургский государственный педиатрический медицинский университет» Минздрава РоссииФГБОУ ВО «Cанкт-Петербургский государственный педиатрический медицинский университет» Минздрава РоссииPurpose. To examine the indicators of iron deficiency, the levels of hemoglobin, erythropoietin, hypoxia-induced factor 1-alpha (HIF-1α) in the blood of children with anemia and chronic kidney disease C1-5 prior to the dialysis and on its background, receiving and not receiving iron preparations and erythropoietin-stimulating drugs to establish the role of HIF-1α in the regulation of erythropoietin synthesis and erythropoiesis. Results. The patients (n=80) with anemia and chronic kidney disease were divided into 3 groups: Group 1: 32 patients with chronic kidney disease C1-5 prior to the dialysis, not receiving therapy; Group 2: 18 patients with chronic kidney disease C2-5 prior to the dialysis, receiving iron-containing preparations and erythropoietin-stimulating drugs; Group 3: 30 patients with chronic kidney disease C3-5 on dialysis, receiving iron preparations and erythropoietin-stimulating drugs. Group 1: we found the increased levels of erythropoietin (28.65 ± 3.66 MIU/ml) and HIF-1α (0.089 ± 0.011 ng/ml; p=0.014 and p=0.005, respectively); Group 2: 63.01 ± 14.84 mIU/ml and 0.138 ± 0.025 ng/ml; p=0.0088 and p=0.005, respectively). Group 3: we found the increased level of HIF-1α (0.098 ± 0.01 ng/ml; p=0.005).Conclusion. An increase in concentration of HIF-1α in children with anemia and chronic kidney disease C1-5 prior and on dialysis receiving and not receiving therapy with iron-containing drugs and erythropoietin-stimulating agents confirms the role of HIF-1α in the regulation of erythropoietin and erythropoiesis synthesis in anemia.https://www.ped-perinatology.ru/jour/article/view/1061дети, анемия, хроническая болезнь почек, эритропоэтин, гипоксией индуцированный фактор 1-альфа, hif-1α.
spellingShingle E. V. Leonteva
N. D. Savenkova
Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
Rossijskij Vestnik Perinatologii i Pediatrii
дети, анемия, хроническая болезнь почек, эритропоэтин, гипоксией индуцированный фактор 1-альфа, hif-1α.
title Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
title_full Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
title_fullStr Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
title_full_unstemmed Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
title_short Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
title_sort research of the level of erythropoietin and hypoxia inducible factor 1 alpha in the blood of children and adolescents with anemia at stage c1 5 of chronic kidney disease
topic дети, анемия, хроническая болезнь почек, эритропоэтин, гипоксией индуцированный фактор 1-альфа, hif-1α.
url https://www.ped-perinatology.ru/jour/article/view/1061
work_keys_str_mv AT evleonteva researchoftheleveloferythropoietinandhypoxiainduciblefactor1alphainthebloodofchildrenandadolescentswithanemiaatstagec15ofchronickidneydisease
AT ndsavenkova researchoftheleveloferythropoietinandhypoxiainduciblefactor1alphainthebloodofchildrenandadolescentswithanemiaatstagec15ofchronickidneydisease